Navigation Links
Ensil Canada is Launching a New Medical Device: Publicly Traded Companies Are Invited to Acquire This Technology or Partner with Ensil Canada on the Marketing and Distribution of This New Device
Date:1/8/2014

NEW YORK, Jan. 8, 2014 /PRNewswire/ -- Ensil's team of researchers and engineers have developed a medical device with patented technology that will help patients who suffer from mobility issues caused by spinal cord injuries, strokes or muscle disorders.

This product is called Vastusys (www.vastusys.com), and it works by replicating normal communication between the brain and the limbs via a proprietary, patented technology developed by Ensil. The product utilizes Ensil's innovative bluetooth protocol technology and multiple sensors to enable muscle movement and improve mobility.

"This is truly a ground-breaking achievement that will improve the lives of so many people," said Mr. Farsad Kiani, CEO of Ensil Canada. "I am excited to extend an open invitation to publicly traded companies to either acquire this technology or partner with Ensil to market and distribute this medical device to people around the world."

Ensil is currently inviting publicly traded companies to express interest in either acquiring the new technology or partnering with Ensil on the marketing and/or distribution of the Vastusys medical device.

Ensil Canada is a member of the Ensil group of companies (www.ensil.com), and it focuses on enhancing mission-critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's Research and Development division's mission is to develop new technologies or improve existing technologies, leveraging its in-house aerospace, defence and medical technology expertise, research and resources.

For nearly 30 years, a fundamental belief in "Innovation Beyond Imagination" has been part of Ensil's corporate culture. Since its inception, the company has built its brand in the North American Aerospace and Defence industries as a boutique engineering and R&D technology leader that is striving to improve the quality of life of people globally via innovative ideas and technologies.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Ensil Canada Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
2. Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories
3. Canada-based Radimetrics Announces Expansion to Scotland
4. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
5. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
6. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
7. VirtualScopics Receives Issuance of Influential Patent in Canada
8. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
9. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
10. Sensus Healthcare Announces Health Canada Approval
11. New Treatment For Obstructive Sleep Apnea Now Available In Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):